Table II.

Comparison of the autoantibody-positive rate between different DILI patient groups.

	Gender distribution		Age distribution		Medication time		CHILD classification			Clinical classification
Characteristics	Male	Female	≥55 years	<55 years	≥30 days	<30 days	Class A	Class B	Class C	Hepatocellular type	Cholestatic type	Mixed type
Autoantibodies (+)	89	162	89	147	183	63	59	140	61	153	60	41
Autoantibodies (−)	66	107	73	115	83	95	57	83	24	86	41	43
P-value	0.608		0.841		0.000			0.009			0.051

DILI, drug-induced liver injury.